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Abstract: Emerging research provides substantial evidence to classify strawberries as a functional 
food with several preventive and therapeutic health benefits. Strawberries, a rich source of 
phytochemicals (ellagic acid, anthocyanins, quercetin and catechin) and vitamins (ascorbic acid 
and folic acid), have been highly ranked among dietary sources of polyphenols and antioxidant 
capacity. We conducted a 12 week randomized controlled trial to investigate the dose-response 
effects of freeze-dried strawberries (25 or 50g/day) in lipids and biomarkers of lipid oxidation in 
obese subjects with dyslipidemia, vs. calorie and fiber-matched controls. Anthropometrics, blood 
pressure and biochemical variables were measured at screen and 12 weeks of the study. Study 
findings showed a significant decrease in diastolic blood pressure in the low dose strawberry 
group from baseline to 12 weeks. In addition, when analyzing the change over the 12 week study 
period in the low dose strawberry group, diastolic blood pressure significantly decreased when 
compared to the low dose control. Results showed high dose strawberry supplementation 
significantly decreased oxidized LDL and malondialdehyde (MDA) versus baseline (p<0.05). In 
addition, high dose strawberry supplementation also revealed a decreasing trend in total and LDL 
cholesterol (p=0.07 and p=0.006, respectively). Serum MDA in the high dose strawberry group 
significantly decreased when compared to high dose controls (p<0.05). No effects were noted in 
glucose, hemoglobin A1c, systolic blood pressure and body weight after strawberry 
supplementation. Thus, strawberries may selectively lower markers of lipid oxidation and may be 
incorporated as part of a heart healthy diet in obese subjects with dyslipidemia. 
Funded by the California Strawberry Commission. Also, supported by GCRC at OUHSC. 
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CHAPTER I 
 
INTRODUCTION 
 
 According to the American Heart Association (AHA), cardiovascular disease (CVD) can 
be defined as hypertension (HTN), coronary heart disease (CHD), including myocardial 
infarction (MI) and angina pectoris, heart failure, stroke, and congenital cardiovascular defects.
1
 
In the United States, an estimated 82.6 million people, approximately one in three American 
adults, have one of more types of CVD: HTN (76.4 million), CHD (16.6 million), MI (7.9 
million), angina pectoris (9 million), heart failure (5.7 million), stroke (7 million), and congenital 
cardiovascular defects (650,000 to 1.3 million).
1
 CVD is the leading cause of death in the United 
States and throughout the world according to the AHA
1
. CVD accounted for 33.6% of all deaths 
in 2007 and one out of every three deaths in the United States. 
 Epidemiological studies have found an association between increased consumption of 
fruits and vegetables and decreased risk of CVD and CVD mortality.
20,24 
Specific dietary nutrients 
abundant in fruits and vegetables may be responsible for certain CVD protective properties. An 
increased interest in fruits, specifically berries, has lead to the recognition that berries contain 
high concentrations of fiber and antioxidants, as well as rich sources of polyphenols. 
Strawberries, rich in the polyphenols anthocyanins, have been linked to a reduced risk of CVD 
mortality and CVD risk factors.
20
 Studies have shown that in subjects with cardiovascular risk 
factors, supplementation of strawberries in combination with other berries can increase HDL 
 
2 
 
cholesterol and decrease systolic blood pressure compared to a control group.
28
 These limited 
human studies provide very intriguing results that call for future research and examination of the 
cardiovascular effects of strawberries in subjects with metabolic risk factors.  
 The goal of this study was to investigate the effects of freeze-dried strawberries in 
metabolic risk factors for CVD in a randomized clinical trial. Parameters assessed included 
measures of adiposity, lipid profile, glucose metabolism, as well as markers of oxidative stress in 
subjects with dyslipidemia and abdominal adiposity versus age-gendered matched control at 
baseline and 12 weeks after strawberry supplementation. 
The null hypotheses examined in the study are as follows: 
 Freeze-dried strawberry supplementation will have no effects in anthropometric 
measures and blood pressure compared to control 
 Freeze-dried strawberry supplementation will have no effects in hemoglobin A1c, 
glucose, lipid profile, and markers of lipid oxidation compared to control 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
Cardiovascular Disease (CVD) Statistics: 
The American Heart Association (AHA) Disease and Heart Statistics reported 
“cardiovascular disease is the leading cause of death in the United States and throughout the 
world
1
, and that approximately 45% of adults in the United States have a total cholesterol (TC) 
level of 200mg/dl or above, and about 16% have a total cholesterol level above 240mg/dl.
1
 They 
also reported that the mean total serum cholesterol of adults in the United States decreased from 
204mg/dl to 199mg/dl in the years 1999 to 2008.
1 
Approximately 33% of adults have a high low-
density lipoprotein (LDL) cholesterol level (>130mg/dl), while only 16% have a low high-density 
lipoprotein (HDL) cholesterol level (<40mg/dl).
1
  
Heart disease is the number one killer of Oklahomans.
1
 According to the National Vital 
Statistics Report in 2009, more than 1 out of 4 deaths in Oklahoma are due to heart disease and 
9,602 Oklahomans died from heart disease in 2007, which is 27.7% of total deaths in Oklahoma.
1
 
Risk factors for heart disease and stroke in Oklahoma in 2007 included adults who are current 
smokers (25.5% OK; 17.9% US), adults who did not participate in exercise (47.1% OK; 50.6% 
US), and adults who are overweight or obese (67.4% OK; 63.4% US).
1 
According to the AHA, 
 
4 
 
obesity has reached epidemic proportions in the United States. In Oklahoma three out of five 
people are overweight or obese.
1
 In 2009-2010, more than one-third (35.7%) of the U.S. adult 
population were obese.
2
 Ninety one percent of Oklahoma’s counties have  20% of their 
population that is considered obese.
1 
Overweight and obesity are associated with many health 
risks, such as heart disease, high blood pressure, high blood cholesterol, type 2 diabetes, and 
depression.
1 
 
According to the Center for Disease Control and Prevention (CDC), in the United States 
and worldwide, about 90% to 95% of all diagnosed cases of diabetes are type 2 diabetes (T2D).
2
 
The American Diabetes Association (ADA) also reported that 25.8 million (8.3%) children and 
adults in the United States have diabetes. Statistics also reported that there are 7 million people 
who have still not been diagnosed with T2D and 79 million people who are prediabetics.
3
 Type 2 
diabetes is not an equal opportunity disease, the elderly and different ethnicities are not equally 
affected.
4
 Of the elderly population, 26.9% are reported to have diabetes in the United States.
3
 
The prevalence of diabetes in non-Hispanic whites 20 years or older is 7.1% of the U.S. 
population, and the prevalence for other groups of similar age is as follows: 8.4% of Asian 
Americans, 12.6% of non-Hispanic blacks, 11.8% of Hispanics: 7.6% of Cubans, 13.3% of 
Mexican Americans, and 13.8% of Puerto Ricans.
3
 
According to the AHA, approximately 74 million American adults, or one in three adults 
(31.3%), have hypertension. In 2008, hypertension was listed as the primary or contributing cause 
of more than 348,000 deaths in the U.S.
2  
In 1948, the National Heart, Lung, and Blood Institute, previously known as the National 
Heart Institute knew very little about cardiovascular disease, but they knew that the number of 
deaths from CVD was steadily increasing. Thus, they recruited many researchers to begin a 
project known as the Framingham Heart Study.
11
 The objective of the study was to distinguish 
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risk factors, which contribute to CVD. The basic plan of the study was to examine the 
development of CVD over a long period of time in a large group of participants who had not yet 
developed or suffered from the symptoms of CVD, including heart attack and stroke.
11
 5,209 men 
and women with ages ranging from 30 to 62 were recruited for the study that took place in 
Framingham, MA.
11
 The first group recruited began in 1948 with physical exams and lifestyle 
analysis to aid in recognizing factors associated with CVD development. The participants 
returned every two years for lab tests and physical exams. In 1971 a second generation of recruits 
joined the study, this second group consisted of 5, 124 men and women who were the original 
participants children and their spouses. Many more recruits were added in 1994, 2002 and in 
2003.
11
 Over the many years of research the Framingham study identified major risk factors of 
CVD including, high blood pressure, high blood cholesterol, smoking, obesity, diabetes, and 
physical inactivity, which leads to the scope of the literature review.  
Obesity & Abdominal Adiposity: 
Obesity is defined as an excess proportion of total body fat. A person is considered obese 
when his/her weight is  20% normal body weight.4  The most common way to measure for 
obesity is by their body mass index or BMI, using height and weight as measurements. Table 1 
represents classifications of weight based on BMI.  
Table 1: Classification of Weight/Health status based on BMI 
BMI Weight  Status Health Risk 
Below 18.5 Underweight 
With < 16 suggests possible eating 
disorder and other disease risk* 
18.5-24.9 Normal Healthy, low health risk 
25.0-29.9 Overweight  
Associated with increased risk of 
disease** 
30.0-39.9 Obese 
Associated with further increased 
6 
 
risk of disease 
40 and above Morbidly Obese 
Experiencing obesity-related health 
problems 
*Diseases associated with underweight include chronic obstructive pulmonary disease, cancer, and congestive heart 
failure. 
** Diseases associated with overweight and obesity includes diabetes mellitus, CVD, and hypertension. 
Source:  Nelms, M., Sucher, K.P., Lacey, K., & Roth, S.L. (2011). Nutrition Therapy & Pathophysiology 2e. Belmont, 
CA: Wadsworth Cengage Learning. 
  “Morbid obesity” means that a person is either 50%-100% over normal weight, more than 
100 pounds over normal weight, has a BMI of 40 or higher, or is sufficiently overweight with 
severe health conditions.
4 
Obesity occurs when a person consumes more calories than he or she 
expends. For most people, obesity results when they consume too much food and are physically 
inactive, but there are other factors such as age, gender, genetics, environmental factors, physical 
activity, psychological factors, illness, and medication. Obesity is positively associated with 
dyslipidemia, hypertension, physical inactivity, and diabetes.
4
 Disease risk and obesity can also 
be measured by waist circumference or abdominal adiposity. A man with a waist circumference  
40 inches and a woman  35 inches are considered obese and at high risk for diseases such as 
type 2 diabetes, hypertension, and CVD.
4 
Metabolic Syndrome, although not a disease itself, is a group of risk factors that are 
closely related to those of obesity.
4
 The risk factors include, hypertension, high blood sugar, 
unhealthy cholesterol levels, and abdominal fat. Not only does metabolic syndrome relate to 
obesity, but it also plays a role in dyslipidemia and increases the risk for diabetes by five times; it 
can also double the risk of heart disease, which can lead to heart attacks and stroke.
5
  
Dyslipidemia:  
Dyslipidemia is a condition marked by abnormal lipid or lipoprotein concentrations 
within the blood 
6
; it refers to a lipid profile that increases the risk of atherosclerotic 
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development.
4
 It has often been associated in persons with type 2 diabetes and atherosclerosis. 
Atherosclerosis is a chronic inflammatory disease characterized by the formation of plaque within 
the innermost layer of the arterial wall, substantial cell death and the thickening of the 
surrounding connective tissues.
7,8
 At the site of inflammation there is an accumulation of low-
density lipoproteins (LDL), cholesterol, monocytes, macrophages, and fat-laden foam cells; this 
accumulation is known as plaque formation. Once the accumulation begins LDL particles 
undergo oxidation, which is mediated by monocytes resulting in the inflammatory response.
9
  
Dyslipidemia can also be defined as a condition in which LDL levels and/or triglyceride 
levels are increased and high-density lipoprotein (HDL) levels are decreased.
6
 Table 2 below 
shows an interpretation of lipid profile values related to a person health status according to the 
Adult Treatment Panel III (ATP III) guidelines in 2004.
10
  
 
Table 2. ATP III Classification of LDL, Total, and HDL Cholesterol (mg/dL) 
LDL Cholesterol HDL Cholesterol 
<100 mg/dL Optimal <40 mg/dL 
Low; A major risk 
factor for heart 
disease 
100-129 mg/dL 
Near optimal/Above 
optimal 
40-59 mg/dL Normal 
130-159 mg/dL Borderline high 60 mg/dL and above 
High; Protective 
against heart disease 
160-189 mg/dL High 
Triglycerides 
190 mg/dL and above Very high 
Total Cholesterol <150 mg/dL Normal 
<200 mg/dL Desirable 150-199 mg/dL Borderline high 
200-239 mg/dL Borderline high 200-499 mg/dL High 
240 mg/dL and above High 500 mg/dL or above Very high 
8 
 
Source: Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, 
Stone NJ, for the Coordinating Committee of the National Cholesterol Education Program. Implications of Recent 
Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation. Adult 
Treatment Panel III Guidelines 2004; 110:227-39. 
 
HDL particles are involved in reversing the transport of cholesterol; they transport 
cholesterol from the different tissues to the liver, which reduces plaque build up.
4
 Serum LDL 
levels are the single strongest indicator of cardiovascular risk; they are also the most involved in 
the atherosclerotic process.
10
 Oxidation of LDL causes them to be altered where they are more 
likely to be taken up and used as plaque.
10
 This development of plaque begins as a fatty and 
fibrous growth in the lumen of the vascular wall vessels, and overtime it may calcify.
10
 This 
plaque may result in decreased blood flow, which could lead to myocardial infarction, coronary 
heart disease, peripheral vascular disease, or congestive heart failure.
10
 
Dyslipidemia also affects endothelial dysfunction. The endothelium is the single celled 
lining that covers the internal surface of many blood vessels and body cavities. It plays the role of 
maintaining homeostasis within the vascular walls. When this homeostatic balance is interrupted, 
it cause vasoactive factors to come into concern such as, vasomotion, smooth muscle 
proliferation, thrombosis, inflammation, coagulation, fibrinolysis, and oxidation.
12 
Endothelial 
dysfunction is defined as “the loss of one of more of the vasoactive functions with resultant 
vascular decomposition.”12 Endothelial dysfunction is extremely important if atherosclerosis is 
preexisting, because it promotes plaque instability and rupture, which could lead to the 
development of coronary syndromes.
12
 
Arterial stiffness is also an important factor contributing to cardiovascular disease risks. 
Arterial stiffness is defined as “a hallmark of the aging process and the consequence of many 
disease states such as diabetes and atherosclerosis… it is also a marker for increased 
cardiovascular disease risk, including myocardial infarction, heart failure, and total mortality, as 
9 
 
well as stroke, dementia, and renal disease.”13 It develops due to changes involving the structural 
and cellular elements in the blood vessel.
13
 Arterial or vascular stiffness could also increase due 
to “extrinsic factors” such as hormones, salt, and glucose regulation.13 
Type 2 Diabetes:  
Type 2 diabetes (T2D) was once known as non-insulin dependent diabetes mellitus 
(NIDDM) or adult-onset diabetes, but NIDDM describes more of a condition rather than 
characteristics of a disease.
3
 T2D is the most commonly diagnosed form of diabetes. In T2D, 
either the pancreas does not produce enough insulin or the body produces insulin but the body 
tissues are insulin resistant. This causes an increased need for insulin, so the pancreas must 
increase production.
3; 4
 Insulin is necessary for the body to be able to use glucose for energy. T2D 
is associated with insulin resistance in the peripheral tissues such as, the skeletal muscle and 
adipose tissue. The body is resistant to insulin because the synthesis or mobilization of glucose 
transporters is diminished. In muscle cells and adipocytes the glucose transporters are not able to 
move into the plasma membrane.  People at high risk for developing T2D are those individuals 
who are obese or overweight, women who have gestational diabetes, those with family members 
who have T2D and those with metabolic syndrome. Also those individuals who smoke, have 
inactive lifestyles, or have certain dietary patterns have an increased risk of developing T2D.
4 
Impaired fasting glucose and diabetes are closely associated with the risk of CVD. An 
impaired fasting glucose is defined as plasma glucose between 100 and 125 mg/dL.
3
 There are 
three blood glucose tests to determine if a person has T2D, they are the fasting plasma glucose 
(FPG) test, the A1C test, and the oral glucose tolerance test (OGTT). The FPG is a test that 
measures an individuals blood glucose after at least 8 hours without eating. This test is used to 
determine if the individual has diabetes or prediabetes. Diabetes is diagnosed if the result is 126 
mg/dl or above and prediabetes is diagnosed when the FPG result is 100 to 126mg/dl.
 
The A1C 
10 
 
test measures the average blood glucose level over two or three months. Diagnoses of diabetes is 
made with values at 6.5% or higher and the A1C for prediabetes is between 5.7% and 6.4%. The 
OGTT is taken two hours after drinking a measured amount of a glucose solution. If the person is 
diabetic fasting plasma glucose will be 200 mg/dl or higher and for a prediabetes fasting plasma 
glucose will be between 140 and 200 mg/dl. 
Hypertension:  
Hypertension is both a cardiovascular condition and a risk factor for other forms of CVD; it is 
defined as a chronic elevation in blood pressure (BP).
4
 The heart follows a repetitive cycle of 
contraction or systolic to relaxation or diastolic, termed the cardiac cycle. Systolic BP is when the 
ventricles are contracting due to the force exerted by the blood on the blood vessel walls. 
Diastolic BP is simply the relaxation of the ventricles. A measurement of BP is expressed using 
the reading for systolic pressure as the first (higher) number and the reading for diastolic pressure 
as the second (lower) number. The classifications of BP are represented in Table 3. Hypertension 
is referred to as the “silent killer,” because there are typically no symptoms. It can cause 
congestive heart failure, kidney failure, myocardial infarction, stroke, and aneurysms if left 
untreated.   
Table 3: Classification of blood pressure for adults 
Blood Pressure SBP DBP 
Classification mmHg mmHg 
Normal <120 and <80 
Prehypertension 120–139 or 80–89 
Hypertension, Stage 1 140–159 or 90–99 
Hypertension, Stage 2 ≥160 or ≥100 
SBP, systolic blood pressure; DBP, diastolic blood pressure 
Source: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure. 
11 
 
National High Blood Pressure Education Program. 
Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug. 
There are two types of hypertension, primary and secondary.
4
 Primary hypertension is 
idiopathic, meaning there is no known cause and is about 90% of all diagnosed cases. Lifestyle 
factors such as diet (excessive sodium intake, low potassium intake, and excessive alcohol 
intake), lack of exercise, smoking, stress, and obesity may all contribute to the development of 
primary hypertension. Secondary hypertension is mostly due to other problems already occurring 
such as renal disease, other CVD, endocrine disorders, and neurogenic disorders. 
Oxidative Stress:  
Oxidation is the process of removing electrons from an atom or molecule. This can be a 
destructive change; for example, rusting iron is due to oxidation.
14
 Almost every living thing 
needs oxygen to survive, but in high concentrations oxygen can be toxic and corrosive. Oxidative 
stress is a controlled metabolic process that can generate harmful products. These harmful 
products are known as free radicals, which are highly reactive unstable atoms or molecules 
capable of removing electrons from any other molecules they meet in an effort to achieve 
stability. During this process they create even more unstable molecules that attack their 
neighboring cells in a chain-like reaction. Oxidative stress takes place when there is an impaired 
balance between free radical production and antioxidant capacity, which results in an 
accumulation of damaging oxidative products: such as reactive oxygen species (ROS) and 
reactive nitrogen species (RNS).
 
 The primary ROS formed mainly in the mitochondria is known as superoxide anion.
14
 
This free radical has been implicated in the pathophysiology of many chronic diseases and is the 
precursor to the chain reaction in the formation of the ROS and lipid radicals. These product 
indicators include damaged DNA bases, protein oxidation products, and lipid peroxidation 
12 
 
products.
4
 Oxidative stress may also be due to environmental factors, such as radiation, toxins in 
air, food and water, and smoking.
11
 
There is a significant increase in oxidative stress in individuals with hyperglycemia and 
metabolic syndrome. There are two types of oxidative stress: mitochondrial and inflammatory. 
Mitochondrial oxidative stress is associated mostly with cancer and diabetes, while inflammatory 
oxidative stress is associated more with atherosclerosis.
14 
 
The body does have a defense mechanism to form barriers against free radical 
production. These defense mechanisms include enzymes that break down the reactive form of 
oxygen, and antioxidants (vitamin C and vitamin E) in the diet, which can diminish free radical 
production by providing them with electrons to end the chain reactions.
14
 These essential 
enzymes, for instance superoxide dismutase (SOD) and the GSH antioxidant enzyme system, and 
antioxidants are part of the ROS formation pathway; their goal is to prevent the formation of the 
damaging free radicals and to keep the beneficial enzyme systems and co-factors functioning. 
SOD is generating within body cells and functions in reducing the superoxide anion to the less 
damaging hydrogen peroxide molecule. The pathway then continues with the GSH enzymes, 
glutathione peroxidase (GPX) and glutathione reductase (Gred). GPX neutralizes hydrogen 
peroxide to water and molecular oxygen. This reaction uses GSH as a co-factor due to the 
molecules proton donating qualities. GSH in its reduced form is oxidized to GSSG, which is then 
reduced back to GSH by the enzyme Gred. Gred uses NADPH as a co-factor to finish out these 
complementary reactions.  These two reactions must happen simultaneously within the body in 
order to maintain the GSH/GSSG ratio.
 
The essential vitamins C and E play a major role in functioning within the ROS pathway 
as antioxidants.
15
 They are known to reduce lipid radical formation within the cells and to slow or 
diminish the lipid peroxidation process. Once the lipid peroxyl radical is formed it could follow 
13 
 
one of two pathways. The most ideal pathway is that the lipid peroxyl radical is reduced by the 
reduced form of vitamin E resulting in the formation of lipid hydrogen peroxide and vitamin E 
radical.
  
The lipid hydrogen peroxide can be further reduced to water and molecular oxygen by 
the GSH enzyme GPX using GSH as its co-factor. The vitamin E radical is reduced by the 
teamwork of vitamin C and GSH. These vitamins are working together to regenerate each other in 
order to continue their antioxidant functions.  
If the antioxidant capacity is low and does not reduce this radical it follows the lipid 
peroxidation pathways, which leads to the production of very harmful lipid oxidation products 
known as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These oxidation products 
further lead to DNA damage, direct damage to the macronutrients, and decreased cell signaling.
15
  
Free radical damaged cells may play a role in heart disease.
11
 Oxidation damage is a 
major contributor to cancer, heart disease and Alzheimer’s disease. These toxins seem to 
accumulate over time into more permanent free radicals, so as a person ages they have higher 
levels of these toxins that are related to chronic diseases.  
Inflammation: 
 Inflammation is a naturally occurring pathophysiological process within the body. It has 
been implicated mostly in individuals with chronic disease, but also occurs to some extent in 
healthy individuals.
16
 It is an immune system response to inflammatory stimuli that result in the 
release of an excess amount of molecules known as primary inflammatory cytokines from 
monocytes.
16
 Monocytes are primary immune cells found in the body that function in the 
formation and release of primary inflammatory cytokines.
16 
Examples of primary inflammatory 
cytokine molecules include tumor necrosis factor–alpha (TNF-) and (IL-1).16  Inflammatory 
stimuli are released when there is an increase in inflammatory challenges. There are a wide 
variety of inflammatory stimuli such as  
14 
 
 Trauma 
 Stress 
 Any immune challenge, and 
 Bacterial, viral or fungal toxins. 16 
 
There are also stimuli that is mostly related to CVD and risk factors, which include 
 Diet high in saturated fat 
 Obesity 
 Hyperglycemia 
 Insulin resistance 
 Hypertension, and 
 Smoking16 
When the body is in a state of inflammatory stress, brought about by stimuli, the endothelium, or 
innermost layer of blood vessel tissue, becomes inflamed.
16
 The inflamed endothelium along with 
decreased levels of HDL cholesterol allows monocytes to adhere to the tissue. This process is the 
initiation of atherosclerosis.
 
 Once the endothelium layer becomes inflamed the integrity of the 
tissue decreases allowing the migration of the monocytes into the intima, where they will reside 
until they are mature. Monocytes within the intima mature into macrophages, which engulf 
oxidized lipids leading to the formation of foam cells. Foam cells are still considered to be cells 
of the immune system; therefore they continue secreting inflammatory cytokines. This continuous 
secretion leads to the weakening and eventually rupture of the fibrous cap that was formed by 
smooth muscle cells around the fatty streaks or plaques. Plaques are the final products and are 
formed from foam cells, lipids, cytokines and some calcium. Thrombotic conditions arise once 
the fibrous cap ruptures. Once blood comes into contact with the plaques blood clots are formed 
which restricts blood flow. This can result in a heart attack, stroke or other major condition 
depending on where the blood clot is formed in the body.
 
 
15 
 
Phytochemicals:  
The term “phyto” simply means plant, therefore when discussing phytochemicals a 
simple enough definition would be chemical compounds produced from plants.
8
 Phytochemicals 
can also be defined as dietary bioactive compounds and functional foods, but are not considered 
to be a class of nutrients.  According to the International Food Information Council, functional 
foods are defined as foods that provide health benefits beyond basic nutrition. Diets rich in fruits, 
vegetables, whole grains, nuts and legumes provide the added health benefits that phytochemicals 
offer. They also function as antioxidants by scavenging free radical, such as superoxide anion and 
hydroxyl radical.
15
 This mechanism leads to an increase in the plasma antioxidant status. Another 
function of phytochemicals as antioxidants is that they become concentrated within the lipids 
resulting in a decrease in the oxidation of LDL. Through increased consumption of exogenous 
antioxidants the body is able to up regulate endogenous antioxidant defense mechanisms. This 
allows for the regeneration of the GSH enzyme system as well as many other beneficial factors 
within the body. Phytochemicals break down into many different subgroups and those break 
down into even more subclasses making this area of science a very broad and continually 
researched topic. Phytochemical subgroups are shown in Figure 1, but are not limited to:  
Figure 1: Classification of dietary phytochemicals 
16 
 
 
Source: Liu, Journal of Nutrition. 134: 3479S-3485S; 2004 
The two phytochemicals that have the most relevance to this review are carotenoids and 
phenolics, specifically flavonoids.
8
 Other classes of phytochemicals not listed in figure 1 include:  
 
 Chlorophyll and chlorophyllin,  
 Curcumin,  
 Fiber,  
 Garlic,  
 Indole-3-carbinol,  
 Lignans (phytoestrogens),  
 Phytosterols,  
 Resveratrol, and  
 Soy isoflavones (phytoestrogens)8 
 
Carotenoids account for the yellow, red and orange colors in plants. Fruits and vegetables 
provide sufficient amounts of carotenoids in the human diet.  The most common carotenoids are 
categorized into two broad groups:
8
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 Carotenes 
o α-carotene  
o β-carotene  
o Lycopene 
 
 Xanthophylls 
o β-cryptoxanthin  
o Lutein 
o Zexanthin8 
 
Alpha-carotene, beta-carotene and beta-cryptoxanthin are known as “provitamin A carotenoids.”8 
This means that they can easily convert to retinol by the body, while the other carotenoids cannot. 
Vitamin A is an essential vitamin for normal human growth and development. Vitamin A plays a 
large role in vision, inadequate amounts of vitamin A could lead to a condition known as “night 
blindness.” Carotenoids also function as antioxidants to scavenge molecular oxygen before it 
becomes oxidized.
 
Flavonoids are a class of widely consumed plant-based phytochemicals. Numerous 
studies have shown that they significantly decrease risk factors for many chronic diseases.
17
 
Flavonoids are mostly found in fruits, vegetables, nuts, cocoa, as well as in tea and red wine. 
Flavonoids are bioactive polyphenols that cannot be broken down in a human’s digestive system. 
They function as potent antioxidants to reduce the likelihood of free radical formation; they are 
also anti-inflammatory, they reduce oxidized-LDL, and regulate endothelial nitric oxide (eNOS) 
synthesis. Table 4 shows the flavonoid classes, the subclasses or compounds that make them up 
and some common sources found in the diet.  
Table 4: Flavonoid Classes, Compounds, and Sources  
  Respective Compounds Common Plant Sources 
Flavonoid Class    
   Anthocyanidins  
Cyanidin, delphinidin, malvindin, 
Blueberries, red wine, strawberries 
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pelargondin, peonidin, petunidin 
   Flavan-3-ols 
 
Epicatechin, epicatechin 3-gallate, 
epigallocatechin, epigallocatechin gallate, 
catechin, gallocatechin 
Apples, black tea, blueberries, 
chocolate, red wine 
   Flavanones  Eridictyol, hesperetin, naringenin Citrus fruit and juices, herbal tea 
   Flavones  Apigenin, luteolin Celery, garlic, green peppers, herbal tea 
   Flavonols 
 
Isorhamnetin, kaempferol, myricetin, 
quercetin 
Blueberries, garlic, kale, onions, 
spinach, tea, broccoli, red wine, cherry 
tomatoes 
   Proanthocyanidins 
Monomers, dimers, trimers, 4-6mers, 7-
10mers, polymers 
Apples, black tea, blueberries, 
chocolate, mixed nuts, peanuts, red 
wine, strawberries, walnuts 
   Isoflavones 
 
Daidzen, genistein, glycitein, coumestrol, 
formononetin, biochanin A Soy products, peanuts 
Total Flavonoids    
  >50 mg/100g   
Apples, black tea, blueberries, 
chocolate, garlic powder, grapefruits, 
grapes, herbal tea, mixed nuts, oranges, 
pears, red wine, strawberries, walnuts 
   >50 mg/serving
1
   
Apples, black tea, blueberries, 
chocolate, grapefruit juice, grapefruit, 
grapes, herbal tea, oranges, pears, red 
wine, strawberries 
1Serving sizes that are predefined on the food-frequency questionnaire are available from www.cancer.org and  
  are generally similar to those of the USDA Nutrient Database of Common Reference (http://www.ars.usda.gov). 
Source: McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, & Dwyer JT. (2012). Flavonoid intake and cardiovascular disease 
mortality in a prospective cohort of US adults1-4. American Journal of Clinical Nutrition, 95: 454-464. 
 
Berry phytochemicals:  
 Berry phytochemicals include the subgroup of flavonoids called anthocyanins.
18
 These 
are the red, blue and purple colors that constitute the berry pigments. Berries are a commonly 
consumed fruit in the U.S. and worldwide. Subgroups of anthocyanins are listed in Table 4, 
which also provides common dietary plant sources. Anthocyanins offer many health benefits. 
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They have strong antioxidant properties, which reduce or inhibit reactive oxygen species.
17
 
Dietary sources of anthocyanin-rich foods consist of blackberries, blueberries, red grapes, 
raspberries, strawberries, plums, and red wine. Intake of anthocyanins has been estimated to 
exceed 200 mg/day.
18
 Studies have also reported that even with relatively low intakes of 
anthocyanins there is a reduced risk for chronic disease. The following table (table 5) gives the 
flavonoid content, calories and fiber content for the different fruits associated with increased 
cardiovascular health. 
TABLE 5: Fruit Total 
anthocyanidi
n 
content 
(mg)* 
Total 
flavan-3-
ols 
(mg)† 
Total 
flavonol
s 
(mg)‡ 
Calori
es 
(kcal) 
Fib
er 
(g) 
Vitam
in 
C 
(mg) 
Vitam
in 
E 
(mg) 
Blackberry   90.46 42.5   2.49   43 5.3   21 1.17 
Blueberry 163.52 51.71   9.72   57 2.4     9.7 0.57 
Bilberry 430.91   4.13 NF NF NF NF NF 
Chokeberry, raw 437.22 NF   8.90 NF NF NF NF 
Cranberry juice (unsweetened) NF   0.92 20.82   46 0.1     9.3 1.20 
Cranberry juice cocktail     0.46   0.19   1.79   54 NF   42.3 0.22 
Cranberry (dried, sweetened)     0.72 NF   6.91 NF NF NF NF 
Cranberry sauce (canned, sweetened)     0.14 NF   5.11 151 1.0     2.0 0.83 
Currant, black, raw 272.44   1.17 12.69   63 NF 181 1.0 
Mulberries, raw NF NF   2.47   43 1.7   36.4 0.87 
Black raspberry 324.02 NF NF NF NF NF NF 
Red raspberry (raw)   38.68   6.63   1.32   52 6.5   26.2 0.87 
Strawberry   33.63   4.51   1.6   32 2.0   58.5 0.29 
20 
 
 
Basu, A., Rhone, M., & Lyons, T. J. (2010). Berries: Emerging impact on cardiovascular health. Nutr Rev, 68(3), 168-
177. 
 
Berries contain large amounts of anthocyanins and make it fairly easy to consume the 
recommended daily amounts. Although strawberries do not contain as much anthocyanin content 
as other berries, they have a very high vitamin C content, which acts synergistically with other 
antioxidants including polyphenols.
18
 Berries have many beneficial effects in the physiological 
system. They are antioxidants, anti-inflammatory, anti-hyperlipidemic, anti-hypertensive, as well 
as anti-proliferative. Strawberries are considered one of the most commonly consumed fruits in 
the U.S. along with blueberries and cranberries.
19
 Blueberries contain significant amounts of folic 
acid, fiber, and vitamin C, which explain their high antioxidant activity within cells. Multiple 
studies have shown that blueberries play a role in lowering lipid oxidation as well as decreasing 
harmful DNA damaging molecules such as MDA. Cranberry phenolic content depends on the 
form that is consumed. Cranberries are not usually consumed fresh due to their bitter, tangy taste. 
They are more commonly consumed as a sweetened juice. Unsweetened cranberry juice is a good 
source of total flavonols, better than strawberries and blueberries combined.  
Fruit & Vegetable Consumption: 
 According to the AHA, Americans are advised to consume at least 2½ cups of vegetables 
and 2 cups of fruits every day, along with grains, dairy and protein.
1
 These recommendations are 
set to be sure that Americans are consuming daily vitamins and minerals from food that will 
benefit their health and help with weight management, but do Americans really follow these 
recommendations? A balanced diet high in fruits and vegetables has proven to be beneficial in 
reducing the risks for many chronic diseases, including CVD, stroke, and cancer.
20
 Cities and 
states have implemented more community and local approaches in order to increase fruit and 
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vegetable consumption. They have advertised and improved local farmers markets and programs 
aiming to improve overall consumption of local produce. Americans should focus on increasing 
their daily consumption of fruits and vegetables, especially dark green, orange, and red 
vegetables. This is crucial for present and future dietitians to help Americans comprehend and 
implement the new recommendations into their daily lives in order to better their patient’s health.  
 Diets high in fruit and vegetable consumption have been found to be associated with a 
reduced risk of CVD morbidity and mortality.
21
 Two prospective cohorts by Hung et al.
21
, 
evaluated the relationship between fruit and vegetable consumption and the incidence of chronic 
diseases in healthy healthcare professionals. Fruit and vegetable intake was associated with a 
modestly significant decrease in the development of chronic diseases (P=0.07). Of the specific 
fruit and vegetable groups, only green leafy vegetables showed a statistically significant 
association with lower risk among the participants (P=0.01). Researchers concluded that the 
moderate significant decrease is primarily geared toward a decreased risk of CVD and not for 
cancer. A similar study by Liu et al.
22
 focused on fruit and vegetable intake and CVD risk in 
female health professionals. They observed a significant decrease in CVD risk in participants who 
consumed fruits and vegetables in the highest quintiles as well as a lower risk of MI. Consuming 
5 or more servings of fruits and vegetables per day leads to better outcome measures and a 
healthier lifestyle.  
Strawberries:  
 Strawberries are a popular fruit in the United States. They are the fourth highest in 
production behind grapes, oranges and apples, and they are fifth highest in fruit consumption 
behind bananas, apples, oranges, and grapes.
23
 Strawberries may be consumed in many different 
ways including fresh, frozen, in jams or jellies, and also, freeze-dried, which are usually added to 
cereals and juices. They are high in vitamins, phytochemicals, and phytosterols. As mentioned 
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previously, strawberries are excellent sources of antioxidants. They contain significant amounts 
of phytochemicals, including over 40 phenolic compounds. The vibrant red color that 
strawberries exhibit is due to anthocyanins, which make up about 13% of the flavonoid capacity 
along with other flavonoids such as 24% ascorbic acid and 19% ellagitannins that increase the 
antioxidant capacity.
24
  
 There have been many human studies investigating the effects of strawberries and 
cardiovascular health or risk of chronic disease in humans, specifically in CVD, CVD risk 
factors, and mortality caused by CVD. In the Women’s Health Study, conducted by Sesso et al.24 
the prospective association of strawberry intake with CVD risk in 38,176 women as well as the 
cross-sectional association of strawberry intake with lipids and CRP in 26,966 women for an 
average of 10.9 years were examined. Strawberry intake was assessed at baseline using a 131 
item semiquantitative food frequency questionnaire, as well as other factors including self-
reported lifestyle, clinical, and dietary factors. Categories for strawberry consumption were 
divided into four groups: none, 1-3 servings/month, 1 serving/week, and ≥ 2 servings/week. 
Blood taken at baseline was assayed for lipid parameters and CRP. This study defined total CVD 
as confirmed myocardial infarction, stroke, coronary artery bypass graft surgery, percutaneous 
transluminal coronary angioplasty, and CVD mortality.  
Strawberry intake was strongly and significantly associated with varying baseline 
characteristics.
24
 Women, who consumed greater amounts of strawberries tended to be older, 
exercised more often, did not smoke or smoked less, and were currently using post-menopausal 
hormones (p< 0.00001). In the prospective study, higher intakes of strawberries were not 
associated with risk of CVD (p=0.28) as well as for specific cardiovascular endpoints (all 
p>0.05). However, there was a suggestion of a lower risk of CVD mortality when strawberries 
were consumed ≥ 1 serving/week, but evidence was limited due to a low case count. In the cross-
sectional study, total cholesterol and LDL cholesterol were moderately lower in the groups that 
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consumed higher amounts of strawberries, despite that there was not a relationship between 
strawberry intake and the relative risk of higher plasma lipids levels (p>0.05). Furthermore, after 
adjusting for lifestyle, clinical, and dietary factors, CRP had a borderline significant 14% lower 
likelihood of a value ≥ 3 mg/L in women who consumed ≥ 2 servings of strawberries per week (P 
value trend=0.012). This could mean that there is a possible decrease in an inflammatory 
response associated with higher consumption of strawberries. The study concluded that 
strawberry intake was not associated with the risk of a CVD event, lipid parameters, or CRP in 
women, though increased strawberry consumption may slightly reduced the likelihood of having 
elevated CRP levels.  
In the Iowa Women’s Health Study, Mink et al.20 evaluated the prospective association 
between flavonoid intake and CVD mortality in 34,489 post-menopausal women. Results from 
this study concluded that they found a significant inverse relationship between consumption of 
strawberries and CVD mortality after 16 years of follow-up. Yu et al.
25
 reported significant lipid 
profile improvement with purified anthocyanin supplementation for 12 weeks in subjects with 
dyslipidemia versus a control. Jenkins et al.
26
 showed antioxidant effects in 28 hyperlipidemic 
subjects complying to a portfolio diet for 2.5 years after one-month strawberry consumption in 
reducing oxidative damage to LDL. Other studies have reported a positive association between 
cardiovascular health and strawberry anthocyanin intakes.   
Clinical Studies:  
Table 6 summarizes the human intervention studies solely focused on strawberry intake. It gives 
the basics of their research as well as methods to explain how they found their results.   
Table 6: Summary of Human Intervention Studies using fresh or processed strawberry 
products 
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Source Duration Study design Study subjects Control Strawberry 
intervention 
Significant 
findings 
(p<0.05) 
Cao et al. 
in 199827 
Postprandial Controlled trial Healthy female 
subjects (n=8) 
Coconut drink 240g 
strawberries  
Increase in 
vitamin C and 
antioxidant 
capacity  
Paiva et 
al. in 
199828 
Postprandial Controlled trial Healthy elderly 
women (n=7) 
378mL 
coconut drink 
240g 
strawberries  
Decrease 
plasma 
carotenoids  
Chung et 
al. in 
200229 
Four days Three 
consecutive 
control days 
followed by 
experimental 
agents on the 
fourth day 
Healthy 
volunteers 
(n=40) 
Control diet: 
low in NDMA, 
nitrate, amine, 
sulfur 
compounds, 
ascorbic acid 
and phenolic-
compound-
containing 
food items 
Experimental 
diet 
containing 
whole 
strawberries 
(300g), 
Decrease in 
NDMA 
excretion 
following 
whole 
strawberry 
intake 
Prior et 
al. in 
200730 
Postprandial Randomized 
cross-over 
multicentered 
trial  
Healthy women 
(n=7) 
None Seascape’ 
strawberries 
(300g)  
Increase in 
postprandial 
whole plasma 
antioxidant 
capacity in 
strawberry 
group  
Erlund et 
al. in 
200831 
8 weeks Randomized, 
single-blind, 
placebo-
controlled, trial 
Subjects with 
cardiovascular 
risk factors 
(n=72) 
One of four 
control 
products each 
day to match 
the energy 
intake in the 
berry group; 
2dL sugar-
water, 100g 
sweet semolina 
porridge, 100g 
sweet rice 
porridge, or 
40g marmalade 
sweets 
2 portions of 
berries daily; 
whole 
bilberries 
(100g) and a 
nectar of 50g 
crushed 
lingonberries 
every other 
day; black 
currant or 
strawberry 
puree and 
cold-pressed 
chokeberry 
and raspberry 
juice on 
alternating 
days  
Inhibition of 
platelet 
function; 
Increase in 
HDL-
cholesterol; 
Decrease in 
systolic BP in 
berry group 
Jenkins et 
al. in 
Ten weeks Randomized 
cross-over 
study with 2-
Hyperlipidemic Oat bran bread 
(65g/day) 
Fresh 
strawberries 
Decrease in 
oxidative 
damage to LDL 
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200826 week washout 
phase 
subjects;(n=28)  (454g/day) in strawberry 
group; 
maintained 
Decrease in 
LDL-
cholesterol as 
result of 
previous 
dietary 
regimen; 
Increase dietary 
palatability  
Basu et 
al. in 
200932 
Four weeks Baseline and 
Post-
intervention 
effects  
Women with 
metabolic 
syndrome 
(n=16) 
None 50g of freeze-
dried 
strawberry 
powder as 
beverage  
Decrease in 
total and LDL-
cholesterol and 
lipid 
peroxidation  
Basu et 
al. in 
201033 
Eight weeks Randomized 
controlled trial 
Men and 
women with 
metabolic 
syndrome 
(n=27) 
Four cups 
water 
50g of freeze-
dried 
strawberry 
powder as 
beverage  
Decrease in 
total and LDL-
cholesterol, 
small LDL 
particles, and 
vascular cell 
adhesion 
molecule 
Torronen 
et al. in 
201034 
Postprandial Randomized 
controlled 
cross-over trial 
Healthy men 
and women 
(n=12) 
Control meal: 
250 mL water, 
35g sucrose, 
4.5g glucose, 
5.1g fructose  
Mixed berry 
puree (150g) 
consisting of 
black 
currants, 
bilberries, 
European 
cranberries 
and 
strawberries, 
with 35g 
sucrose 
Decrease 
postprandial 
glucose at 15 
and 30 min and 
in 
berry versus 
control group; 
smaller peak 
Increase in 
glucose from 
baseline in 
berry group 
Henning 
et al. in 
201035 
Three weeks Baseline and 
Post-
intervention 
effects 
Healthy female 
volunteers 
(n=21) 
None 250g frozen 
strawberries 
daily for 3 
weeks  
Increase in 
serum 
antioxidant 
capacity 
Burton-
Freeman 
et al. in 
201036 
Postprandial 
and twelve 
weeks  
Randomized 
placebo-
controlled 
crossover trial 
Hyperlipidemic 
men and women 
(n=24) 
Placebo 
beverage 
matched for 
calories, 
carbohydrates 
and sugars 
10g freeze-
dried 
strawberries ~ 
110g/day of 
fresh 
strawberries  
Postprandial 
lipemia and 
oxidized LDL 
were 
significantly 
decrease 
following high-
fat meal 
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challenge with 
strawberries  
Zunino et 
al. in 
201137 
7 weeks Double-blind, 
randomized, 
cross-over trial 
healthy subjects 
(n=20) 
Two servings 
of strawberry 
flavoring and 
red food color 
in yogurt, 
cream cheese, 
or water-based, 
sweetened 
beverage 
Two servings 
of strawberry 
powder in 
yogurt, cream 
cheese, or 
water-based, 
sweetened 
beverage 
Decrease 
plasma concen- 
trations of 
cholesterol and 
small HDL-
cholesterol 
particles, and 
increase LDL 
particle size in 
obese subjects  
 
 
Strawberries and antioxidant capacity 
Henning et al.
35
 conducted a crossover intervention study in 2010 focused on the impact of 
strawberry consumption on antioxidant capacity. During this 3 week study, 250 grams of frozen 
strawberries were consumed daily at breakfast, by 21 healthy female participants. The authors 
state that 2,5-Dimethyl-4-hydroxy-3-[
2
H]furaone (DMHF) is an important flavor constituent that 
gives strawberries their distinct aroma. DMHF is widely used industrially in food and beverages 
as a flavoring agent due to its pleasant taste and odor; it has also been found to be highly 
bioavailable after consumption of at least one large dose of strawberries, about a 2.5 to 3 kg dose. 
It is believed that this component of strawberries may be responsible for the modest increases in 
antioxidant defense following interventions.  
 They chose to measure oxidative damage to lipids in serum and not in isolated LDL 
fractions because most of the phytochemicals in strawberries are assumed to be in the aqueous 
phase of serum.
35
 In this study, each 250g serving of frozen strawberries provided at least 
164.5mg of Pg-3-glucoside, 3.7mg of ellagic acid and 3mg of DMHF daily. Urinary 
concentrations of DMHF were significantly increased at the end of the strawberry intervention in 
19 of the 21 participants and returned to baseline level at the end of the washout period (p < 
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0.05).  DMHF urinary concentrations were found at its highest in the 0-12 hour urine sample and 
were decreased in the 12-24 hour urine sample. Lipid peroxidation lag time increased from 
baseline in both fasting (25.4 ± 21.0 to 31.5 ± 22.9) and non-fasting (25.0 ± 19.6 to 31.1 ± 24.6) 
serum (p < 0.05). LDL oxidation lag phase returned to baseline levels after a washout period of 
three weeks. Lipid peroxidation lag time increased by 20% indicating that daily consumption of 
strawberries resulted in a slightly significant increase in antioxidant capacity in healthy female 
participants (p < 0.01). Henning et al.
35
 suggested that consumption of 250g of strawberries 
everyday for 3 weeks decreased oxidative damage likely from the increase seen in antioxidant 
capacity in serum, which has potential to improve the body’s defense against chronic disease. 
Strawberries, lipids, and blood pressure 
In an 8 week single-blind, randomized, placebo-controlled intervention trial, Erlund et al.
31
, 
which took place in 2008, aimed to investigate the effects of berry consumption on HDL 
cholesterol, platelet function and blood pressure (BP) in 72 middle-aged unmedicated subjects 
with CVD risk factors. Subjects were randomized into either the berry group (n=35) or the 
control group (n=36). Subjects in the berry group consumed 2 portions of berries daily, 100g 
whole bilberries and 50 g crushed lingonberries every other day and 100 g of black currant or 
strawberry puree and 0.7 mL of cold-pressed chokeberry and raspberry juice on the alternative 
days. The control group consumed 1 of 4 different calorie-control products each day. Researchers 
found that systolic blood pressure (SBP) in the berry group was significantly different from 
control. SBP significantly decreased by 1.5 mmHg in the treatment group and slightly increased 
by 0.5 mmHg in the control group (P = 0.050). On the other hand, diastolic blood pressure (DBP) 
did not change in the berry group, but slightly increased by 0.9 mmHg in the control group (P = 
0.044). In the subgroup analysis conducted on SBP, the difference between groups was 
significant only in the highest tertile. Within the highest tertile, the mean decreases in SBP were 
7.3 and 0.2 mmHg in the berry and control groups, respectfully (P = 0.024). These findings 
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suggested that berry supplementation had a greater influence on systolic blood pressure in higher 
ranges. 
 In addition, researchers found that total serum cholesterol and triacylglycerol were 
unaffected by the berry intervention.
31
 Despite that, serum HDL-cholesterol concentrations 
increased significantly more in the berry group by 5.2% (0.08 mmol/L) than in the control group 
(0.6%; 0.01 mmol/L) (P = 0.006). Researchers put these findings into perspective by reporting 
that for each 1% increase in HDL cholesterol there is a 1% decrease in the cardiovascular event 
rate.  
 Platelet function was measured using a platelet function analyzer studying closing time 
when collagen and ADP were used as platelet activators.
31
 A short closing time may be a novel 
risk factor for acute coronary syndromes. Erlund et al.
31
 found that berry consumption 
significantly inhibited platelet function, as measured by CADP-CT (P = 0.018). Supplementation 
with berries was found to significantly increase collagen and ADP closing time by 11% (8.4 
seconds) compared to a decrease of 1.4% (1.2 seconds) in the control group. Favorable changes in 
platelet function were demonstrated by an increase in platelet aggregation time this indicates that 
berries increase cardiovascular health by reducing the risk of clotting. 
 The results of this study implied that the consumption of moderate amounts of berries 
resulted in positive changes in blood pressure, HDL cholesterol, and platelet function, which 
leads to the conclusion that regular consumption of multiple types of berries may play a role in 
the prevention of CVD versus just consuming one type of berry.
31
  
Strawberries, lipid profile & lipid peroxidation 
Many studies have taken place focusing on the effects of antioxidants (mainly 
strawberries) and CVD risk.
32,33
 Some factors of CVD that saw a decrease in patients with 
metabolic syndrome with the addition of strawberries were elevated blood pressure, 
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hyperglycemia, dyslipidemia, and inflammation. Dietary intervention by increasing strawberry 
intake has been shown to decrease markers of lipid profile in several clinical studies.  
In a study conducted by Basu et al.
32
 in 2009, 16 women with metabolic syndrome 
consumed 50g of freeze-dried strawberry powder for 4 weeks. Again, this study tested the 
hypothesis that FSP will lower fasting lipids and biomarkers of oxidative stress and inflammation 
at 4 weeks compared to baseline. The study concluded that total cholesterol (-5%) and LDL 
cholesterol levels (-6%) significantly decreased at 4 weeks versus baseline (P < 0.05), as well as 
lipid peroxidation in the form of malondialdehyde and hydroxynonenal (-14%, p < 0.01). 
Oxidized LDL cholesterol showed a decreasing trend in the 4 weeks (P = 0.123) and no 
significant differences on any other measurements were seen.
 
Limitations are the same for both 
studies, but this study had no control. Researchers concluded that short-term supplementation of 
freeze-dried strawberries appeared to have hypocholesterolemic effects as well as significantly 
decreased lipid peroxidation in women with metabolic syndrome. 
In a randomized controlled trial conducted by Basu et al.
33 
in 2010, researchers 
hypothesized that freeze-dried strawberry powder (FSP) supplementation would improve clinical 
features of metabolic syndrome associated with atherosclerotic markers of CVD. The primary 
objective was to assess changes in lipid profiles including lipoprotein particle size and 
concentrations along with other biomarkers after FSP supplementation or control treatment for 8 
weeks in obese subjects with metabolic syndrome. Twenty seven subjects with an average BMI 
of 37.5 and average age of 47 years old completed the study. The subjects were randomized into 
the control group (4 cups of water a day) or the strawberry group (2 cups strawberry beverage + 2 
cups of water a day) for 8 weeks. The intervention was a 50g FSP beverage, which is equal to 
approximately 500g of fresh strawberries or about 3 cups of sliced strawberries.  
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Strawberry supplementation significantly decreased total and LDL cholesterol levels in 
subjects with metabolic syndrome.
33
 The study concluded that the strawberry supplementation 
caused a 10% decrease in total cholesterol (5.8 ± 0.2 to 5.2 ± 0.2 mmol/L), as well as an 11% 
decrease in LDL cholesterol (3.5 ± 0.2 to 3.1 to 0.1 mmol/L) at the end of 8 weeks compared to 
the control (P < 0.05). Supplementation of FSP did not affect triglycerides, HDL cholesterol, or 
VLDL cholesterol. Limitations of the study included the small sample size as well as the absence 
of a dose-response study design. The study also lacked a matched energy and fiber control group, 
which may be more appropriate for future studies. These findings correlate with the hypothesis 
that freeze-dried strawberry supplementation decreases atherosclerotic risk factors, such as total 
and LDL cholesterol in subjects with metabolic syndrome. 
Strawberries and postprandial metabolism:  
Strawberries and postprandial antioxidant capacity 
In a study by Cao et al.
27
 in 1998, seven healthy elderly women were recruited to investigate the 
effects of strawberries, spinach, red wine or vitamin C on serum total antioxidant capacity. Total 
antioxidant capacity was determined using different methods including: oxygen radical 
absorbance capacity (ORAC) assay, Trolox equivalent antioxidant capacity (TEAC) assay and 
ferric reducing ability of plasma (FRAP) assay. An increase in the area under the curve (AUC) in 
serum and urinary ORAC and FRAP demonstrated an increase in total antioxidant capacity when 
240g of strawberries were consumed. The increases in the AUC for ORACPCA and FRAP were 
13% and 10%, respectively, compared to control. Urinary ORAC excretion after the consumption 
of strawberries showed an increase of 9.6% and was significantly higher than the control (p < 
0.05). The increases in serum and urinary antioxidant capacity following the consumption of 
strawberries indicated a direct absorption and/or increased production of antioxidants. The 
contribution of vitamin C to the increased serum ORACPCA and FRAP was only 8-14% and the 
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contribution of urate to the increased serum ORACPCA and FRAP was 39-42% following 
consumption of the strawberry drink. It is clear that other antioxidant phenolic compounds found 
in strawberries contribute to the other half of the increased serum antioxidant capacity following 
strawberry consumption. 
 In addition, continued analysis in 1998 by Paiva et al.
28 
, examined the postprandial 
plasma responses of carotenoids following consumption of strawberries, red wine, vitamin C or 
spinach in the same seven elderly women in the study by Cao et al.
27
 Out of the five beverages 
studied only the spinach beverage had a significant source of carotenoid content. The control 
intervention had no significant difference in carotenoid levels from baseline, but the strawberry 
beverage had lower postprandial carotenoid concentrations from baseline. However, for most 
carotenoids, strawberry feeding resulted in significantly lower carotenoids values from baseline at 
11 and 15 hours postprandial (p <0.05). Strawberry intervention also significantly lowered LDL 
cholesterol by 14.1% after 1 hour from baseline (p < 0.05). Paiva et al.
28
 hypothesized that 
strawberries may have played a role in interfering with the secretion of carotenoids into the 
circulation based on the findings from this study. 
Strawberries and postprandial lipid metabolism 
 In a randomized, single-blind, placebo-controlled, 12 week crossover trial by Burton-
Freeman et al.
36
 in 2010, the postprandial effects of strawberry supplementation on in response to 
a high fat meal, about 28% fat, in 24 participants with dyslipidemia were investigated. 
Participants, first, at baseline, consumed a 10 g freeze-dried strawberry or a macronutrient 
matched controlled beverage and a high fat meal and second, after 6 weeks of consuming a 
strawberry or control beverage daily, both groups ingested a high fat meal with a control beverage 
only, without a strawberry beverage. The authors found that acute and chronic strawberry 
supplementation helps to protect a postprandial rise in serum levels after a high fat meal.  
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 Results indicate that there was a significant increase in triglycerides, HDL cholesterol, 
and oxidized LDL in the postprandial state under both the acute and chronic experimental 
conditions (P < 0.0001).
36
 However, after consuming strawberry beverages with a high fat meal, 
there was a significant reduction in postprandial triglycerides (P = 0.005), HDL cholesterol (p = 
0.003), and oxidized LDL (P = 0.0008) compared to the control. Reduction of triglycerides may 
be beneficial in decreasing CVD risk. The results of this study supported the hypothesis that 
strawberry phenolic compounds decrease postprandial lipemia and LDL oxidation with a high fat 
meal. Triglyceride concentrations significantly increased from baseline after both strawberry and 
control meals, reaching its peak concentration after 4 hours. However, triglyceride concentrations 
were found to be significantly lower after consumption of strawberries. The study also showed 
that daily strawberry consumption in the form of a beverage for 6 weeks had a persistent 
beneficial effect on postprandial lipemia.  
Conclusion: 
 Cardiovascular risk factors including: obesity, metabolic syndrome, hypertension, 
dyslipidemia, and, diabetes are all strongly associated with atherosclerotic CVD and CVD 
mortality. Dietary management of these specific and serious conditions can prevent or reverse the 
severity and even the condition itself. Several human studies have been conducted to investigate 
the cardioprotective benefits of strawberries in healthy subjects. Strawberries are a good source of 
polyphenolic anthocyanins, micronutrients, vitamin C, and fiber. They have been shown to 
increase antioxidant capacity as well as to increase HDL cholesterol and decrease systolic blood 
pressure. To date, there have been no reported studies investigating the long-term, dose-response 
strawberry supplementation in subjects with CVD or CVD risk factors, which therefore leads us 
to the scope of our study. 
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CHAPTER III 
 
 
MATERIALS AND METHODS 
 
Participants  
Following approval from the Institutional Review Board (IRB) for both Oklahoma State 
University (OSU) and University of Oklahoma (OU), men and women with abdominal adiposity 
and dyslipidemia were recruited from the Clinical Research Center (CRC) at the University of 
Oklahoma and at the Department of Nutritional Sciences (NSCI) at Oklahoma State University 
through flyers and campus e-mail advertisements. Participants had an initial telephone screen and 
then were scheduled for a screening visit. Subjects were qualified through inclusion and exclusion 
criteria. After qualification, 40 subjects were randomized to match for age and gender. Eleven 
subjects were enrolled in each the high dose strawberry intervention and the high dose control 
groups and 9 subjects were enrolled in the low dose strawberry intervention and low dose control 
groups. Those in strawberry intervention groups consumed freeze-dried strawberry powder (FSP). 
Inclusion criteria 
Subjects were included based on inclusion criteria: 
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 Abdominal adiposity (men >40 inches, women >35 inches), dyslipidemia (two of four 
criteria: fasting total cholesterol >200 mg/dL, triglycerides   >150 mg/dL, low density 
lipoprotein (LDL) –cholesterol >100 mg/dL, or high density lipoprotein (HDL)-
cholesterol (men <40 mg/dL, women <50 mg/dL), normal liver, kidney, and thyroid 
function tests, stable multivitamin/mineral supplements or prescription medications 
(except   hypolipidemic, hypoglycemic, and steroid agents), males and females, as 
well as any ethnic group.  
Exclusion criteria 
Subjects were excluded based on exclusion criteria: 
 Pre-existing disease (e.g. anemia, cancer, heart disease, diabetes [fasting glucose ≥126 
mg/dL]), liver or renal disorders, pregnancy and lactation, consumption of mega doses 
of antioxidants/fish oil supplements (>1 g/day), consumption of hypolipidemia, 
hypoglycemic, and steroid medications, abnormal hemoglobin (Hb) (normal range: 
12.0-18.0 g/dL), white blood cell (WBC)   (normal range: 4.0-11.0 K/mm3), or 
platelets (140-440 K/mm3), hypo/hyperthyroidism (normal range for thyroid 
stimulating hormone: 0.35-4.940 uiu/mL), abnormal liver enzymes (normal range for 
aspartate transaminase (AST): 7-40 units/L;   alanine transaminase (ALT): 10-45 
units/L), abnormal kidney function (normal creatinine: females: 0.7-1.2 mg/dL; males: 
0.8-1.2   mg/dL; normal blood urea nitrogen (BUN): 1-59 years: 7-18 mg/dL; >59 
years: 8-21   mg/dL), as well as smoking and drinking alcohol (>1 oz/day).  
Research design 
Subjects identified with abdominal adiposity and dyslipidemia 
 
Block Randomization (n= 40) 
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Low fiber/calorie control   Low dose FSP         High fiber/calorie control   High dose FSP  
             (n=9)        (n=9) (25g/day)   (n=11)    (50g/day)       
 
12-week intervention (2 cups beverage/day) 
 
Anthropometrics, blood pressure, and blood draws at screen and 12 weeks 
 
Subjects come 3 days/week to CRC/NSCI for compliance 
 
Subjects compensated on a weekly basis 
Intervention and compliance 
Subjects in the low or high dose intervention or control groups consumed 2 cups of 
beverage per day for 12 weeks. In the low dose intervention group, each cup contained 12.5g 
freeze-dried strawberry powder (FSP) blended in 1 cup water with added splenda (optional). In 
the high dose intervention group each cup contained 25g FSP that was blended in 1 cup of water 
with the option of added splenda. The matched controls consumed 2 cups of the control beverage 
per day. Each cup contained 2g fiber (Fiberfast) and 2 tsp sugar blended in 1 cup water in the low 
fiber/calorie control group, or 4g fiber (Fiberfast) and 4 tsp sugar blended in 1 cup water in the 
high fiber/calorie control group. The control beverage also contained a total of 4 tsp artificial 
strawberry flavor, specifically strawberry flavored Koolaid©, as well as 4 drops of red food 
coloring blended in to 2 cups of water per day. The low-dose FSP and matched control group 
consumed equal amounts of fiber (4g) and calories (75 kcal) per day, while the high dose FSP and 
matched controls consumed 8g and 150 kcal per day for 12 weeks. The nutrition composition of 
the FSP and control intervention beverages is listed in Table 7. 
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All subjects made mandatory visits to the research facilities 2-3 days/week to ensure 
compliance. The remaining quantities of beverages were provided in containers for later 
consumption. Height, weight, blood pressure, and waist circumference were measured by trained 
personnel at the Clinical Research Center (CRC) at the University of Oklahoma Health Sciences 
Center (OUHSC) and at Nutritional Sciences department at Oklahoma State University (OSU) at 
screen, 6 weeks, and at 12 weeks of the study. Blood draws were performed by trained nurses at 
CRC and by trained phlebotomists at Stillwater Medical Center in Stillwater. 
Dietary analyses 
All subjects were asked to follow their usual diet and lifestyle but refrain from other sources of 
berries and related products while on the study. Subjects also maintained 3-day food (2 weekday 
and 1 weekend) records at screen, 6 and 12 weeks of the study. Three day averages of micro- and 
macronutrient intakes were calculated using Food Processor (ESHA Research, Salem, OR). If a 
participant consumed a food that was not in the database, an online search of the nutrient 
composition was made or a food with very similar nutrient composition was chosen. 
Clinical variables 
 
TABLE 7: Composition of freeze-dried strawberries and control beverages 
 
Nutritive value 
Freeze-dried 
strawberries (25g)
1 
Freeze-dried 
strawberries (50g)
1 
            Control (25g)
2 
         Control (50g)
2 
 
Calories (kcal) 75 150 80 160 
Protein (g) 
 
1.75 3.5 - - 
Fat (g) 
 
0.25 0.5 - - 
Carbohydrates (g) 25 50 20 40 
Dietary fiber (g) 4 8 4 8 
Ash (g) 
 
1.60 3.17 - - 
Vitamin C (mg) 54.5 109 1.5 3 
Total Phenolics (mg)
3 
1003 2006 - - 
Total Anthocyanins 
(mg)
4 77 154 - - 
Ellagic acid (mg) 20.5 41 - - 
Phytosterols (mg) 25 50 - - 
      1 Ten percent fresh weight; California Strawberry Commission (Watsonville, CA, USA). 
 2 Fiberfast 
   3 Expressed as milligram gallic acid equivalents 
   4 Expressed as milligram cyaniding-3-glucoside equivalents 
   Source: CSC 
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Fasting blood samples, after each draw were immediately sent to OU Medical Center laboratory 
or the Stillwater Medical Center laboratory for comprehensive metabolic panel (CMP) including 
glucose, insulin, glycated hemoglobin, lipid panel, electrolytes, liver, kidney, thyroid tests, and 
complete blood count at each visit. Remaining plasma and serum samples were stored at -80
o
C 
for future analyses.  
Biomarkers of oxidative stress  
Plasma concentrations of oxidized-LDL were measured using enzyme-linked immunosorbent 
assay (ELISA) kits (Mercodia, Uppsala, Sweden) according to the manufacturer’s instructions. 
Lipid peroxidation was measured in serum as malondialdehyde (MDA) using a colorimetric assay 
according to the manufacturer’s protocol (LPO-586TM, Oxis Health Products, Inc., Portland, 
OR). All samples were assayed in triplicates within our established inter assay variations of 10% 
for each variable. 
Statistical analyses 
For all measures, descriptive statistics were calculated and graphs drawn to look for outliers; no 
data points were determined to be outliers. Data are presented as means ± standard deviation in 
the tables. Our primary comparisons for analysis were between (1) the high dose strawberry and 
high dose control group and  (2) the low dose strawberry and low dose control group. 
 Within group comparisons at baseline and 12 weeks for each of the 4 groups were 
conducted using a paired t test. Changes in measurements over the 12-wk study period were 
assessed by calculating the difference between the pre- and postintervention measurements in 
each group; the differences in high dose strawberry versus high dose control and the differences 
in low dose strawberry versus low dose control. Differences were calculated by subtracting 
baseline values minus 12 week values for each group. For each variable, significance was 
38 
 
assessed by comparing the change over the 12-wk study period between high dose strawberry 
versus high dose control as well as between low dose strawberry versus the low dose control 
using Student’s t tests. The sample included a total of 40 total participants (n=11 in both high 
dose groups & n=9 in both low dose groups). Multiple hypothesis testing was not accounted for, 
but results were reviewed for consistencies. All statistical tests were 2-tailed with significance 
level set at 0.05. SPSS for Windows (version 15.0, SPSS, 2006) was used for the statistical 
calculations. 
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CHAPTER IV 
 
 
RESULTS 
 
A total of 40 participants met the inclusion and exclusion criteria and completed the 
study. Randomization took place as follows: high dose strawberry group (n=11), high dose 
control group (n=11), low dose strawberry group (n=9), low dose control group (n=9). All of the 
subjects who were enrolled completed the 12 week study. Additionally, all of the subjects in all 4 
groups adhered to the intervention and compliance was assessed by mandatory visits (2 times per 
week) for monitored drink consumption and recording of any left over amounts of beverages. 
There were no complaints from the participants about adverse effects of strawberry and/or fiber 
supplementation. 
Baseline characteristics 
 Table 8 shows all of the baseline characteristics of the participants. Baseline values of 
hemoglobin A1c and total cholesterol in the low dose strawberry group were significantly 
different versus control (p=0.04 and p=0.01, respectively). Although not significant, LDL 
cholesterol tended to be lower in the low dose strawberry group versus control (p=0.08). No other 
differences were seen in any other parameters. 
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In the high dose strawberry group, baseline values of waist circumference and diastolic 
blood pressure were significantly different versus control (p=0.04 and p=0.05, respectively). 
There were no other differences observed in any other variables.  
Anthropometric measures and blood pressure 
Anthropometric (BMI and waist circumference) and blood pressure measures showed no 
significant difference in the low dose control group at 12 weeks versus baseline (Table 9). 
However, low dose strawberry supplementation significantly decreased diastolic blood pressure 
by 3.3% at 12 weeks versus baseline (p=0.02). When analyzing the change over the 12 week 
period in the low dose strawberry group, diastolic blood pressure significantly decreased by an 
average of 2.67 mmHg when compared to low dose control (2.22 mmHg)(p=0.04).  
 Anthropometrics and blood pressure measures were not significantly different in the high 
dose control group at 12 weeks versus baseline. Similarly, no significant differences in 
anthropometric measures and blood pressure at 12 weeks versus baseline in the high dose 
strawberry group were seen. Also, the 12 week change showed no significant differences between 
the high dose control and high dose strawberry groups. 
Glucose and hemoglobin A1c 
 Fasting glucose showed a decreasing trend of 7.7% (p=0.07) in the low dose control 
group and no change in hemoglobin A1c at 12 weeks versus baseline. Low dose strawberry 
supplementation did not affect fasting glucose or hemoglobin A1c levels in the subjects at 12 
weeks versus baseline. No changes were observed over the 12 week period in the low dose 
strawberry group when compared to the low dose control group. 
 Hemoglobin A1c significantly decreased by 3.4% in the high dose control group at 12 
weeks versus baseline (p=0.02). In contrast, there was no significant difference in fasting glucose 
41 
 
at 12 weeks versus baseline. No significant differences for hemoglobin A1c and fasting glucose 
were found in the high dose strawberry group at 12 weeks versus baseline. Finally, the 12 week 
change showed no significant difference between the high dose control and high dose strawberry 
groups.  
Lipid profile 
  The low dose control group showed no significant differences in total cholesterol, LDL 
cholesterol, HDL cholesterol, VLDL cholesterol, or triglyceride levels at 12 weeks versus 
baseline. Likewise, the low dose strawberry group showed no significance in lipid profiles at 12 
weeks versus baseline. When analyzing the change over the 12 week period, the decrease in HDL 
cholesterol in the low dose strawberry group was significantly lower (0.11 mg/dL) when 
compared to the low dose controls (0.78 mg/dL, p=0.03). 
 Total, LDL, HDL, and VLDL cholesterol, along with triglycerides, showed no significant 
decreases in the high dose control group at 12 weeks versus baseline. However, high dose 
strawberry supplementation showed decreasing trends in total cholesterol and LDL cholesterol at 
12 weeks versus baseline (p=0.07 and p=0.06, respectively). No changes were observed over the 
12 week period in the high dose strawberry group when compared to the high dose control group 
in these lipid profiles. 
Biomarkers of lipid oxidation 
 Oxidized LDL cholesterol and serum MDA significantly decreased by 6.6% and 11.1% 
respectively, in the low dose control group at 12 weeks versus baseline (p<0.05 and p=0.01, 
respectively). However, low dose strawberry supplementation did not affect ox-LDL or serum 
MDA at 12 weeks versus baseline. When evaluating the 12 week change, the decrease in serum 
MDA in the low dose strawberry group was significantly lower (0.12 μM) when compared to the 
low dose control group (0.28 μM, p=0.03).  
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 Biomarkers of lipid oxidation such as, ox-LDL and serum MDA, decreased significantly 
in the high dose control group at 12 weeks versus baseline as follows: oxidized LDL cholesterol 
decreased by 5.8% (p=0.03) and serum MDA decreased by 11.5% (p<0.05). In our study, high 
dose strawberry supplementation also significantly decreased ox-LDL by 11.2% and serum MDA 
by 26.7% (p<0.05). When assessing the 12 week change, we found serum MDA in the high dose 
strawberry group to be significantly decreased by an average of 0.79 μM when compared to high 
dose controls (0.35 μM, p=0.03). 
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* Significantly different versus control at baseline (0 weeks) (p<0.05) 
Data are means ± standard deviations 
Abbreviations: LDC, low dose control; LDFSP, low dose freeze-dried strawberry powder; HDC, high dose control; HDFSP, high dose 
freeze dried strawberry powder; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, 
hemoglobin A1c; BUN, blood urea nitrogen; LDL, low density lipoprotein; HDL, high density lipoprotein; VLDL, very low density 
lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell; RBC, red blood cell 
 
 
 
 
 
 
 
 
 
	
TABLE 8: Baseline characteristics of participants 
 
Desirable 
Ranges
4
 
LDC LDFSP (25g) HDC HDFSP (50g) 
n 
 
9 9 11 11 
Age (years) 
 
44.9 ± 9.3 49.2 ± 8.9 48.6 ± 10.5 46.5 ± 10.7 
Male/Female (n/n) 
 
2/7 2/7 3/8 4/7 
BMI (wt/m
2
) 18.5-24.9 37.5 ± 5.1 35.5 ± 4.9 34.8 ± 5.7 40.1 ± 7.2 
Waist (in.) 
Men <40 
Women <35 
43.2 ± 3.7 41.5 ± 3.5 41.9 ± 2.9 46.0 ± 5.0* 
SBP (mmHg) <120 128 ± 12.4 125.0 ± 11.3 131.3 ± 12.1 136.5 ± 10.1 
DBP (mmHg) <80 87.7 ± 6.1 80.6 ± 7.6 82.9 ± 3.96 86.5 ± 9.0* 
Glucose (mg/dL) 90-130 103.7 ± 12.7 97.1 ± 11.8 91.5 ± 16.7 92.7 ± 15.5 
HbA1c (%) 4.5-6 5.9 ± 0.8 5.6 ± 0.3* 5.9 ± 0.6 5.8 ± 0.5 
BUN (mg/dL) 6-20 13.7 ± 3.0 12.6 ± 1.9 15.5 ± 3.4 15.3 ± 4.5 
Total Protein (gm/dL) 6-8.3 6.9 ± 0.4  6.9 ± 0.2 7.1 ± 0.4 7.0 ± 0.4 
Total Cholesterol (mg/dL) <200 207.2 ± 22.1 204.9 ± 51.4* 213.5 ± 36.9 215.3 ± 27.9 
LDL (mg/dL) <100 133.1 ± 18.4 121.6 ± 44.0 132 ± 33.2 138.5 ± 28.7 
HDL (mg/dL) 
Men >40 
Women >50 
49.9 ± 12.7 47.8 ± 19.4 45.2 ± 9.6 45.4 ± 17.1 
VLDL (mg/dL) 5-403 22.4 ± 8.2 34.0 ± 18.0 34.5 ± 14.8 37.1 ± 14.1 
Triglycerides (mg/dL) <150 110.4 ± 44.8 170.3 ± 90.6 172.8 ± 73.7 185.5 ± 71.5 
ALT (U/L) 7-56 31.9 ± 14.1 31.8 ± 13.3 28.7 ± 7.2 24.7 ± 6.2 
AST (U/L)  5-40 24.9 ± 6.7 29 ± 12.2 24.8 ± 5.8 23.2 ± 3.5 
WBC (mcL) 4,500-10,000 6.8 ± 1.4 7.2 ± 0.9 6.9 ± 1.7 6.9 ± 2.0 
RBC (cells/mcL) 4-6 4.5 ± 0.4 4.5 ± 0.5 4.7 ± 0.3 4.5 ± 0.5 
Hemoglobin (gm/dL) 12-17 13.3 ± 1.3 13.8 ± 1.4 14.2 ± 1.3 13.7 ± 1.3 
Hematocrit (%) 36-50 39.4 ± 3.6 40.9 ± 4.2 42.1 ± 3.8 40.8 ± 4.5 
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*Significantly decreased at 12 weeks compared to baseline (p<0.05) 
Data are means ± standard deviations 
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; TC, 
total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein; VLDL, very low density lipoprotein; TG, triglycerides; 
ox-LDL, oxidized low density lipoprotein; MDA, malondialdehyde 
 
 
 
 
 
 
 
 
 
TABLE 9. Anthopometric measures, blood pressure, glucose control, lipid panel, and biomarkers of lipid oxidation after 12 week supplementation with 
FSP or control treatment 
 
Desirable 
Range4 
Low-Dose Control (n=9) Low-Dose FSP (n=9) High-Dose Control (n=11)  High-Dose FSP (n=11) 
  
0 week 12 weeks 0 week 12 weeks 0 week 12 weeks 0 week 12 weeks 
BMI 
(kg/m2) 
18.5-24.9 37.5 ± 5.1 37.2 ± 5.2 35.5 ± 4.9 35.5  ± 4.8 34.8 ± 5.7 34.7  ± 5.7 40.1 ± 7.2 39.8 ± 7.8 
Waist 
(inches) 
Men <40 
Women <35 
43.2 ± 3.7 42.9 ± 3.2 41.5 ± 3.5 41.5 ± 3.8 41.9 ± 2.9 42.3 ± 3.4 46.0 ± 5.0 45.9 ± 4.9 
SBP 
(mmHg) 
<120 128.3 ± 12.4 130.3 ± 8.7 125.0 ± 11.3 126.1 ± 14.6 131.3 ± 12.1 131.6 ± 8.3 136.5 ± 10.1 134.1 ± 12.3 
DBP 
(mmHg) 
<80 87.7 ± 6.1 85.4 ± 3.5 80.6 ± 7.6 77.9 ± 8.5* 82.9 ± 3.96 84.6 ± 4.7 86.5 ± 9.0 82.8 ± 8.4 
Glucose 
(mg/dL) 
90-130 103.7 ± 12.7 95.7 ± 8.8 97.1 ± 11.8 92.7 ± 14.9 91.5 ± 16.7 93.5 ± 18.5 92.7 ± 15.5 91.2 ± 14.8 
HbA1c 
(%) 
4.5-6 5.9 ± 0.8 5.9 ± 0.6 5.6 ± 0.3 5.6 ± 0.4 5.9 ± 0.6 5.7 ± 0.4* 5.8 ± 0.5 5.7 ± 0.7 
TC 
(mg/dL) 
<200 207.2 ± 22.1 202.0 ± 40.4 204.9 ± 51.4 208.1 ± 58.9 213.5 ± 36.9 214.1 ± 37.7 215.3 ±27.96 
193.8 ± 
22.96 
LDL 
(mg/dL) 
<100 133.1 ± 18.4 131.8 ± 25.6 121.6 ± 44.0 127.2 ± 57.5 132.0 ± 33.2 129.2 ± 31.3 138.5 ± 28.7 114.2 ± 26.6 
HDL 
(mg/dL) 
Men >40 
Women >50 
49.9 ± 12.7 49.1 ± 17.5 47.8 ± 19.4 47.7 ± 21.2 45.2 ± 9.6 48.0 ± 10.5 45.4 ± 17.1 44.6 ± 11.4 
VLDL 
(mg/dL) 
5-403 22.4 ± 8.2 23.4 ± 12.9 34.0 ± 18.0 29.4 ± 12.1 34.5 ± 14.8 36.4 ± 13.8 37.1 ± 14.1 36.6 ± 10.3 
TG 
(mg/dL) 
<150 110.4 ± 44.8 115.7 ± 65.8 170.3 ± 90.6 147.1 ± 60.7 172.8 ± 73.7 173.5 ± 56.9 185.5 ± 71.5 180.6 ± 53.1 
          
OX-LDL 
(U/L)  
136.2 ± 7.4 127.2 ± 7.6* 127.8 ± 19.9 119.9 ± 17.8 128.5 ± 16.3 
121.1 ± 
17.2* 
137.1 ± 13.8 121.7 ± 9.2* 
MDA 
(uM)  
2.7 ± 0.7 2.4 ± 0.6* 2.4 ± 0.6 2.3 ± 0.5 2.6 ± 0.5 2.3 ± 0.4* 3.0 ± 0.6 2.2 ± 0.4* 
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* Significantly decreased compared to control (p<0.05) 
†  Decrease was significantly lower compared to control (p<0.05) 
Data are means ± standard deviations 
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; TC, 
total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein; VLDL, very low density lipoprotein; TG, triglycerides; 
ox-LDL, oxidized low density lipoprotein; MDA, malondialdehyde 
 
TABLE 10. Change in variables after 12 week supplementation of FSP or control  
 
Δ (0-12 wk) 
 
LDC (n=9) LDFSP (n=9) HDC (n=11) HDFSP (n=11) 
     
BMI (kg/m
2
) 0.29 ± 1.34 0.02 ± 3.76 0.02 ± 6.76 0.27 ± 2.89 
Waist (inches) 0.28 ± 0.75 -0.03 ± 2.12 -0.41 ± 4.62 0.10 ± 3.84 
SBP (mmHg) -2.00 ± 8.96 -1.11 ± 8.02 -0.36 ± 16.48 2.45 ± 17.47 
DBP (mmHg) 2.22 ± 5.12 2.67 ± 2.65* -1.73 ± 5.64 3.72 ± 13.93 
Glucose (mg/dL) 9.11 ± 13.07 4.44 ± 8.65 -1.91 ± 10.89 1.55 ± 10.46 
HbA1c (%) 0.04 ± 0.35 0.05 ± 0.28 0.22 ± 0.27 0.08 ± 0.53 
TC (mg/dL) 5.22 ± 26.99 -3.22 ± 54.89 -0.55 ± 52.22 21.45 ± 35.57 
LDL (mg/dL) 1.33 ± 23.62 -5.67 ± 45.14 2.82 ± 42.78 24.27 ± 38.35 
HDL (mg/dL) 0.78 ± 7.03 0.11 ± 4.01† -2.82 ± 14.16 0.73 ± 10.61 
VLDL (mg/dL) -1.00 ± 9.15 4.56 ± 14.81 -1.82 ± 18.47 0.45 ± 10.72 
TG (mg/dL) -5.22 ± 45.97 23.22 ± 74.74 -0.64 ± 85.60 4.91 ± 54.60 
     
OX-LDL (U/L) 9.00 ± 4.18 7.89 ± 20.09 7.45 ± 9.36 15.36 ± 11.13 
MDA (uM) 0.28 ± 0.22 0.12 ± 0.59† 0.35 ± 0.28 0.79 ± 0.55* 
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CHAPTER V 
 
 
DISCUSSION 
General findings 
 Diastolic blood pressure significantly decreased in the low dose strawberry group from 
baseline to 12 weeks. When analyzing the change over the 12 week period in the low dose 
strawberry group, diastolic blood pressure significantly decreased when compared to the low dose 
control. 
 High dose strawberry supplementation significantly decreased biomarkers of lipid 
oxidation, oxidized-LDL and serum malondialdehyde (MDA), at 12 weeks versus baseline.  
In addition, high dose strawberry supplementation also revealed a decreasing trend in total and 
LDL cholesterol. When assessing the 12 week change in the high dose strawberry group, serum 
MDA significantly decreased when compared to the high dose controls. 
Freeze-dried strawberries 
 In our study, subjects in the low dose strawberry group were supplemented with 25 grams 
freeze-dried strawberries, equivalent to 250 grams of fresh strawberries, or approximately 1.5 
cups of sliced strawberries daily for 12 weeks. Subjects in the high dose strawberry group 
consumed 50 grams freeze-dried strawberries, equivalent to 500 grams of fresh or 3 cups of sliced 
strawberries daily for 12 weeks. 
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The freeze-dried strawberry powder (FSP) was obtained from the California Strawberry 
Commission (Watsonville, CA) and was approximately 10% fresh weight of strawberries and had 
no added ingredients. The FSP doses administered were within the current American Heart 
Association recommendations of at least 5 cups of fruits and vegetables per day for adults and 
provided a concentrated source of strawberry polyphenols, fiber, and micronutrients.
1
 
Furthermore, the strawberry doses selected were based on previous clinical trials that have shown 
health benefits in healthy volunteers or those with CVD risk factors when supplemented with 
fresh strawberry doses ranging from 100 to 500 grams. 
26,32,33,35
  
 Fresh strawberries are processed to various products, such as frozen and dried fruits, 
jams, jellies, puréed, and juice concentrates, in order to enhance shelf life. Freeze-drying is a 
drying technique that significantly retains polyphenol and anthocyanin content of strawberries 
when compared to other methods such as, microwave, convection, and vaccum-drying.
38
 A study 
conducted by Marques et al.
39
 reported that freeze-dried strawberries have higher total antioxidant 
activities when compared to fresh or frozen berries. In our study, freeze-dried strawberries were 
well tolerated by participants; FSP also provided a palatable and convenient source of delivery of 
berry nutrients and polyphenols in order to obtain the health benefits of daily fruit consumption.  
Strawberries and anthropometric and blood pressure measures 
 Anthropometric measures (body mass index (BMI) and waist circumference) did not 
significantly change from baseline to 12 weeks as a result of strawberry intervention, thus our 
study findings did not support our hypothesis. Similarly, other research studies using similar 
doses did not show any significant changes in BMI or waist circumference after long term 
strawberry intervention. 
26, 31-33
  
  However, we saw a significant decrease in diastolic blood pressure (DBP) in the low 
dose strawberry group versus the low dose control group whereas there was no change in systolic 
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blood pressure (SBP). In contrast to these null findings in our study, two studies that analyzed the 
effects of berry consumption in blood pressure showed a significant decrease in SBP: one was 
conducted in middle-aged subjects with cardiovascular risk factors consuming a mixed berry 
intervention
31
 and the other was conducted in healthy men consuming cranberry juice.
40
 It is 
possible that there are many different factors contributing to these differences. First, in the study 
conducted by Erlund et al.
31
 , the intervention consisted of 100 grams mixed berries plus 1 small 
glass of mixed berry drink each day whereas our study intervention was only one single type of 
berry and a lower dosage in both intervention groups. Using mixed berries may have led to higher 
and different profiles of polyphenols and micronutrients compared to our intervention, which may 
have a positive impact in blood pressure. Secondly, the sample size in the study by Erlund et al.
31
 
was double the number in our sample size. In addition, although in both studies subjects were 
prehypertensive, subjects in our study had much higher BMI values compared to the previous 
study. Since obesity is positively associated with hypertension,
4
 a greater dose of strawberry 
intervention and/or longer study duration might produce greater effects in blood pressure than 
what was observed in the present study in obese subjects. 
 Strawberries, glucose and hemoglobin A1c 
 In our study, glucose and hemoglobin A1c concentrations were not significantly affected 
by low or high dose strawberry supplementation. In an acute postprandial study conducted by 
Törrönon et al.
34
, berry purée (150 gram mix of bilberries, blackcurrants, cranberries, and 
strawberries, and sweetened with 35 grams sucrose) supplementation did not show a statistically 
significant difference in the postprandial area under the glucose response curve, but results 
indicated a decreased glucose response due to berry consumption. The duration of the study by 
Törrönon and colleagues was very short compared to our study; the sample size was also 
considerably smaller and the baseline characteristics of the subjects were relatively normal, all of 
these factors could contribute to the differences versus our findings. 
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Strawberries and lipid profile 
 There were no statistically significant differences in lipid profiles at 12 weeks versus 
baseline in the low or high dose strawberry groups. Similarly, when the 12 week change was 
analyzed no statistical significance was shown for either intervention group. Despite the fact that 
total and LDL cholesterol did not show a statistically significant decrease at 12 weeks versus 
baseline, both showed a decreasing trend in the high dose strawberry group, which may have a 
positive biological relevance. The desirable range for TC is less than 200 mg/dL 
4
 and although 
not significant, the mean TC reduced to levels below the desirable range after high dose 
strawberry intervention. The ideal range in LDL cholesterol is less than 100 mg/dL 
4
 and after 
high dose strawberry supplementation mean LDL reduced to levels closer to the desired range. 
These findings in total and LDL cholesterol suggest that a larger sample size, a longer duration 
and/or a more concentrated source of purified strawberry anthocyanins might exert more 
significant changes in these lipid parameters than what was observed in the current study.  
 Conflicting results related to the effects of high and low dose strawberry intervention in 
lipid profile have been reported in other clinical trials. In two clinical studies by Basu et al.
32,33
, 
serum total and LDL-cholesterol levels significantly decreased from baseline and no significance 
was found in other lipid profile variables. The previous study by Basu et al.
32
 did not have a 
control group so the results should be interpreted with caution compared to other studies that 
reported significance with respect to a control group. In addition, another clinical study by Basu 
and colleagues
33
 reported a significant decrease in total and LDL cholesterol in patients 
consuming high doses of strawberry supplementation (50g) for 8 weeks when compared to a non-
intervention control group. In our study, total and LDL cholesterol showed a mean decreasing 
trend from baseline after 12 weeks of high dose strawberry supplementation. The baseline 
characteristics of the participants in all three studies were relatively similar and participants in all 
three studies had two out the three criteria that classifies metabolic syndrome.
5 
Other similarities 
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include, the doses of intervention and form of intervention were the same throughout (50g FSP).  
Our 12 week study duration was longer than both of the previous clinical studies.  
 However, in a study by Erlund et al.
31
 berry intervention did not significantly decrease 
TC, but it did significantly increase HDL cholesterol concentrations compared to control.
 
Supplementing mixed berries could be the explanation behind the significant increase in HDL, 
which is not seen in other studies using a single variety of berry intervention. In another study by 
Jenkins et al.
26
, strawberry supplementation (454 g/d) did not show any significant differences in 
lipid profile parameters compared to a oat bran bread/fiber control. The strawberry intervention in 
this study was different from ours; participants consumed 1 pound of fresh strawberries per 2000 
kcals as part of their daily meal. Similarities between the study by Jenkins et al.
26
 and our study 
include, doses were similar in both, subject were hyperlipiemic, and the controls both consisted of 
fiber. Larger clinical trials may be helpful in interpreting the effects of high and low dose 
strawberry supplementation in lipid profiles. 
Strawberries and biomarkers of lipid oxidation 
 The most notable finding of our study was the significant decrease in serum 
malondialdehyde (MDA) in the high dose strawberry group compared to high dose controls. 
Also, we observed a statistically significant decrease in oxidized-LDL (ox-LDL) and serum MDA 
in the high dose strawberry group at 12 weeks versus baseline. Oxidized LDL is a key factor in 
the development and progression of atherosclerosis.
10
 It has been suggested that ox-LDL 
enhances monocyte accumulation in the subintimal space as well as increasing transition from 
macrophages to foam cells.
10
 A significant decrease in ox-LDL might slow the progression of 
atherosclerosis.
10
 MDA plays a key role in the cellular and DNA damage, so similarly decreases 
in serum MDA may help lessen or alleviate oxidative stress.
15
 
51 
 
The reduction in ox-LDL and MDA and the increase in antioxidant capacity by freeze-
dried strawberry supplementation, which was observed in our study, are consistent with previous 
study results.
26, 32,35
 In a study by Basu et al.
32
, MDA significantly decreased in women with 
metabolic syndrome at 4 weeks versus baseline. In addition, ox-LDL showed a decreasing trend 
at 4 weeks. Subjects in the study by Basu and colleagues consumed a daily dose of 50g freeze-
dried strawberry powder throughout the 4 week study duration. While the doses consumed are in 
comparison with the present study, the study duration was about one-third of our study, which is a 
possible reason as to why our results showed a significant decrease in ox-LDL from baseline and 
a significant between group difference in MDA. The previous study did not have a control group 
and the duration was only 4 weeks, which could be a factor as to why significance was not found 
in ox-LDL.  
In a study conducted by Jenkins and colleagues
26
, 28 hyperlipidemic subjects were 
supplemented with the same amount of strawberries and fiber-calorie matched control used in the 
current study. Following a 4 week intervention, the authors concluded that strawberry 
supplementation significantly decreased oxidative damage to LDL cholesterol, while also 
maintaining a decrease in lipid profile variables. Consumption of flavonoid rich strawberries, 
which have a high polyphenolic content, have also been shown to reduce ox-LDL and MDA 
concentrations, but increase antioxidant capacity.
32,35
 A study conducted by Henning et al.
35
 was 
designed to determine the effects of a 3 week 250g strawberry intervention in oxidative DNA 
damage and antioxidant capacity. The authors concluded that LDL oxidation lag time increased 
by 20% and antioxidant capacity demonstrated a modest, but significant increase. Evaluating lipid 
oxidation lag time has been shown to be a reliable marker to analyze the antioxidant activities of 
different dietary compounds. This study was only 3 weeks compared to our current 12 week study 
and doses of strawberry intervention were equal to our low dose strawberry groups 
supplementation. Oxidative stress and inflammation pathways can function synergistically, so a 
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decrease in markers of inflammation could possibly decrease markers of oxidative stress and vice 
versa. This may be an explanation as to why the fiber control also showed a significant decrease 
in ox-LDL and MDA at 12 weeks versus baseline. Thus, the polyphenols and fiber in the 
strawberries might exert a synergistic effect in producing greater decreases in biomarkers of lipid 
oxidation compared to fiber controls. This remains to be confirmed in future research. 
Limitations 
Major limitations in this current study include the small sample size as well as the 
duration of the study. The small sample size can also be linked to the large standard deviations, 
because a smaller sample size can lead to an increased variability between participants.  
 In the current study we did not control for subjects physical activity and we did not ask 
participants to make any dietary changes throughout the study duration, which could be a reason 
we did not find any significant differences in BMI or waist circumference.  
 Another limitation could be that a fiber-containing beverage was used in the control 
groups versus an inactive control beverage. The control beverage was matched for fiber, which 
has some known effects in lipids. However, we addressed the research question if strawberry 
polyphenols affect metabolic variables and lipid oxidation beyond the known effects of fruit 
fibers. 
 In the current study we measured compliance by participants coming in to our office to 
collect their respective beverages twice per week. We did not measure urinary anthocyanins, 
which is probably a better measure of compliance because of the feasibility and availability of the 
resources.  
Conclusion 
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 In our study, high dose freeze-dried strawberry supplementation significantly decreased 
MDA compared to high dose controls. Also, high dose freeze-dried strawberry supplementation 
along with low and high dose controls significantly decreased biomarkers of lipid oxidation, 
oxidized-LDL and malondialdehyde (MDA), at 12 weeks versus baseline. Diastolic blood 
pressure significantly decreased in the low dose strawberry group (1) at 12 weeks versus baseline 
and (2) compared to low dose controls.  
 Strawberries were found to exert cardioprotective effects in subjects with abdominal 
adiposity and dyslipidemia in the current study. The AHA recommends eating 8 or more fruits 
and vegetable servings per day and an average adult who consumes about 2,000 kcals/day should 
aim for about 4.5 servings per day.
1
 Therefore, increased berry consumption should be 
encouraged as part of a heart healthy diet. Furthermore, it should be promoted in populations with 
low fruit and vegetable intake and in those at a high risk of cardiovascular disease. Future 
research should be focused on increasing the sample size as well as study duration. Further 
studies comparing commercially available strawberry products to freeze-dried strawberry powder 
(used for research purposes only) may help confirm their effects in lipid profile and biomarkers of 
lipid oxidation in subjects at risk for cardiovascular disease. 
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